Abstract
We chose depression as the first BPSD to discuss, not only because of its high prevalence in people with dementia but also because of the challenges in identifying depression in these patients in a busy clinical setting. This difficulty is particularly pronounced because of the overlap of symptoms between the two conditions, the lack of standardized diagnostic criteria, and the low reliability of self-report and informant-based measures. Missing the diagnosis of depression can lead to grave consequences, given its strong association with an increased risk of suicide and the exacerbation of cognitive decline and functional impairment. Moreover, the clinical course, treatment, and prognosis differ significantly between patients with depression and those without. Despite these challenges, there are scales to assist in the assessment and diagnosis of depression in dementia. Additionally, a comprehensive and person-centered treatment approach, integrating both nonpharmacological and pharmacological interventions, can be effective in managing depression in individuals with dementia. Hence, it is crucial for clinicians to possess the necessary knowledge and skills to identify and manage depression in people with dementia.
References
Apostolova LG, Cummings JL. Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord. 2008;25(2):115–26. https://doi.org/10.1159/000112509.
Panza F, Frisardi V, Capurso C, D’Introno A, Colacicco AM, Imbimbo BP, Santamato A, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry. 2010;18(2):98–116. https://doi.org/10.1097/JGP.0b013e3181b0fa13.
Monastero R, Mangialasche F, Camarda C, Ercolani S, Camarda R. A systematic review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis. 2009;18(1):11–30. https://doi.org/10.3233/JAD-2009-1120.
Edwards ER, Spira AP, Barnes DE, Yaffe K. Neuropsychiatric symptoms in mild cognitive impairment: differences by subtype and progression to dementia. Int J Geriatr Psychiatry. 2009;24(7):716–22. https://doi.org/10.1002/gps.2187.
Rosenberg PB, Mielke MM, Appleby B, Oh E, Leoutsakos JM, Lyketsos CG. Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry. 2011;26(4):364–72. https://doi.org/10.1002/gps.2535.
Ismail Z, Elbayoumi H, Fischer CE, Hogan DB, Millikin CP, Schweizer T, Mortby ME, Smith EE, Patten SB, Fiest KM. Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(1):58–67. https://doi.org/10.1001/jamapsychiatry.2016.3162.
Ballard C, Bannister C, Solis M, Oyebode F, Wilcock G. The prevalence, associations and symptoms of depression amongst dementia sufferers. J Affect Disord. 1996;36(3–4):135–44. https://doi.org/10.1016/0165-0327(95)00072-0.
Enache D, Winblad B, Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry. 2011;24(6):461–72. https://doi.org/10.1097/YCO.0b013e32834bb9d4.
Weiner MF, Doody RS, Sairam R. Prevalence and incidence of major depressive disorder in Alzheimer’s disease: findings from two databases. Dement Geriatr Cogn Disord. 2002;13:8–12.
Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA. 1997;277(10):806–12.
González-Salvador MT, Arango C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry. 1999;14(9):701–10.
Lee ATC, Fung AWT, Richards M, Chan WC, Chiu HFK, Lee RSY, Lam LCW. Risk of incident dementia varies with different onset and courses of depression. J Affect Disord. 2021;282:915–20. https://doi.org/10.1016/j.jad.2020.12.195. Epub 2020 Dec 30.
Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961–70.
Kok RM, Reynolds CF 3rd. Management of depression in older adults: a review. JAMA. 2017;317(20):2114–22.
Alexopoulos GS. Mechanisms and treatment of late-life depression. Transl Psychiatry. 2019;9(1):188.
Ghahremani M, Nathan S, Smith EE, McGirr A, Goodyear B, Ismail Z. Functional connectivity and mild behavioral impairment in dementia-free elderly. Alzheimers Dement (N Y). 2023;9(1):e12371. https://doi.org/10.1002/trc2.12371.
Pearson JL, Conwell Y. Suicide in late life: challenges and opportunities for research. Introduction. Int Psychogeriatr. 1995;7(2):131–6. https://doi.org/10.1017/s104161029500192x.
Li X, Xiao Z, Xiao S. Suicide among the elderly in mainland China. Psychogeriatrics. 2009;9(2):62–6. https://doi.org/10.1111/j.1479-8301.2009.00269.x.
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–84. https://doi.org/10.1016/0006-3223(88)90038-8.
Mourao RJ, Mansur G, Malloy-Diniz LF, Castro Costa E, Diniz BS. Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis. Int J Geriatr Psychiatry. 2016;31(8):905–11. https://doi.org/10.1002/gps.4406.
Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry. 2008;16(7):558–67. https://doi.org/10.1097/JGP.0b013e3181693288.
Bishop MM, Fixen DR, Linnebur SA, Pearson SM. Cognitive effects of vortioxetine in older adults: a systematic review. Ther Adv Psychopharmacol. 2021;11:20451253211026796. https://doi.org/10.1177/20451253211026796.
Christensen MC, Schmidt SN, Grande I. Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: the MEMORY study. J Affect Disord. 2023;338:423–31. https://doi.org/10.1016/j.jad.2023.06.024.
Devanand DP, Pelton GH, D’Antonio K, Ciarleglio A, Scodes J, Andrews H, Lunsford J, Beyer JL, Petrella JR, Sneed J, Ciovacco M, Doraiswamy PM. Donepezil treatment in patients with depression and cognitive impairment on stable antidepressant treatment: a randomized controlled trial. Am J Geriatr Psychiatry. 2018;26(10):1050–60. https://doi.org/10.1016/j.jagp.2018.05.008.
Omranifard V, Shirzadi E, Samandari S, Afshar H, Maracy MR. Memantine add on to citalopram in elderly patients with depression: a double-blind placebo-controlled study. J Res Med Sci. 2014;19(6):525–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lee, A.T.C., Mok, V.C.T., Lam, L.C.W. (2024). Depression in Dementia. In: Kim, J.S. (eds) Neuropsychiatric Manifestations in Neurological Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-97-1821-4_6
Download citation
DOI: https://doi.org/10.1007/978-981-97-1821-4_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-97-1820-7
Online ISBN: 978-981-97-1821-4
eBook Packages: MedicineMedicine (R0)